Equities

Evaxion Biotech A/S

EVAX:NAQ

Evaxion Biotech A/S

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (USD)3.15
  • Today's Change0.03 / 0.96%
  • Shares traded71.03k
  • 1 Year change-34.38%
  • Beta-0.2559
Data delayed at least 15 minutes, as of Sep 19 2024 20:30 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Evaxion Biotech A/S is a Denmark-based clinical-stage biotechnology company, which specializes in the development of AI-driven immunotherapies to improve the lives of patients with cancer and infectious diseases. The Company decodes the human immune system to discover and develop immunotherapies to treat cancer and infectious diseases. Based on AI-immunology core technology, Evaxion is developing a pipeline of product candidates. In addition, Evaxion develops portfolio of vaccines to prevent bacterial and viral infections.

  • Revenue in USD (TTM)278.00k
  • Net income in USD-15.21m
  • Incorporated2008
  • Employees49.00
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
AIM ImmunoTech Inc201.00k-28.05m16.63m26.00--2.72--82.72-0.5703-0.57030.0040.10680.0082--12.187,730.77-113.70-45.64-149.16-48.3571.14-231.75-13,952.74-11,695.01----0.3018--43.26-11.26-48.94--35.73--
Cell Source Inc0.00-6.45m16.78m-----------0.1627-0.16270.00-0.4130.00-------1,300.91-1,758.85---------------5.14---------3.55------
OpGen Inc1.96m-22.39m16.88m100.00------8.59-20.01-20.011.66-8.650.1553--6.09---176.99-87.95-15,455.17-127.653.1515.42-1,139.66-794.78---20.25----31.113.0212.38--40.20--
Synlogic Inc3.17m-56.16m17.08m6.00--1.07--5.39-7.24-7.240.35491.370.0628----528,333.30-111.31-40.57-131.17-43.82-----1,771.74-3,245.93----0.00--185.685.9913.40---48.05--
Mira Pharmaceuticals Inc0.00-12.78m17.15m3.00--7.73-----0.8562-0.85620.000.15010.00----0.00-373.77---737.47-------------3.170.00-------69.77------
Galecto Inc0.00-25.43m17.23m13.00--0.6347-----23.45-23.450.0021.740.00----0.00-59.06-48.46-75.34-52.36------------0.00------37.77------
BioVie Inc0.00-37.18m17.31m18.00--0.9117-----9.63-9.630.003.100.00----0.00-94.32-456.35-149.75-1,810.88------------0.2969-------92.67------
Evaxion Biotech A/S - ADR278.00k-15.21m17.56m49.00--13.60--63.18-36.98-36.980.10480.23160.0174--0.34935,673.47-95.08-100.11-126.11-131.65-----5,469.42-131,560.30----0.8933------4.51--65.53--
NRX Pharmaceuticals Inc0.00-24.83m17.63m2.00---------1.62-1.620.00-1.700.00-------197.97-120.57---168.40-----------189.12--------24.14------
Bioxytran Inc0.00-3.51m17.74m2.00---------0.023-0.0230.00-0.00230.00-------2,635.88-1,420.53---------------20.68---------73.71------
Athira Pharma Inc0.00-113.45m17.87m65.00--0.2144-----2.97-2.970.002.170.00----0.00-71.06-30.73-83.81-32.46------------0.00-------23.04------
Cocrystal Pharma Inc0.00-17.93m17.91m12.00--1.03-----1.76-1.760.001.710.00----0.00-61.98-50.94-66.88-52.77-------1,501.78----0.00------53.69--33.34--
Lyra Therapeutics Inc1.82m-101.39m18.39m87.00--0.5938--10.11-1.61-1.610.02940.47330.0165----20,681.82-92.07-58.01-108.51-68.69-----5,570.88-6,235.31----0.00--14.314.60-13.39--95.14--
Spruce Biosciences Inc9.57m-43.11m18.66m22.00--0.3153--1.95-1.05-1.050.23381.430.095----330,069.00-42.79-41.24-52.43-46.49-----450.38-1,774.39---117.260.0412-------3.77------
NanoViricides Inc0.00-9.51m18.67m7.00--1.75-----0.8115-0.81150.000.90170.00----0.00-63.30-43.54-65.85-46.29------------0.00-------5.94---8.90--
Data as of Sep 19 2024. Currency figures normalised to Evaxion Biotech A/S's reporting currency: US Dollar USD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.